
Sign up to save your podcasts
Or


CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP
By American College of Chest Physicians4.2
6262 ratings
CHEST February 2026, Volume 169, Issue 2
CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more.
Moderator:
Peter Mazzone, MD, MPH, FCCP

1,877 Listeners

321 Listeners

504 Listeners

38 Listeners

7 Listeners

36 Listeners

3,374 Listeners

1,150 Listeners

518 Listeners

367 Listeners

260 Listeners

437 Listeners

375 Listeners

59 Listeners

270 Listeners